30 articles for D Guo
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design, Synthesis, and Biological Evaluation of Novel Tetrahydroprotoberberine Derivatives (THPBs) as Selectivea

Chinese Academy of Sciences
5'-Substituted Amiloride Derivatives as Allosteric Modulators Binding in the Sodium Ion Pocket of the Adenosine A2A Receptor.

Leiden University
Structure-kinetics relationships of Capadenoson derivatives as adenosine A1 receptor agonists.

Leiden University
Agonists for the adenosine A1 receptor with tunable residence time. A Case for nonribose 4-amino-6-aryl-5-cyano-2-thiopyrimidines.

Leiden University
Use of receptor chimeras to identify small molecules with high affinity for the dynorphin A binding domain of the kappa opioid receptor.

Adolor
Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites.

National Institute of Diabetes
P3 cap modified Phe*-Ala series BACE inhibitors.

Eli Lilly
Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR.

Eli Lilly
Discovery of Sovleplenib, a Selective Inhibitor of Syk in Clinical Development for Autoimmune Diseases and Cancers.

HUTCHMED Limited
Long-Residence Time Peptide Antagonist for the Vasopressin V2 Receptor to Treat Autosomal Dominant Polycystic Kidney Disease.

Xuzhou Medical University
Benzothiazole derivatives as histone deacetylase inhibitors for the treatment of autosomal dominant polycystic kidney disease.

Xuzhou Medical University
Design and Synthesis of Triazole-Containing HDAC Inhibitors That Induce Antitumor Effects and Immune Response.

Xuzhou Medical University
A Novel Bifunctional μOR Agonist and σ

Sichuan University
2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine tolerance.

Xuzhou Medical University
Optical-Controlled Kinetic Switch: Fine-Tuning of the Residence Time of an Antagonist Binding to the Vasopressin V

Xuzhou Medical University
Discovery of Novel

Shenyang Pharmaceutical University
Long Residence Time at the Vasopressin V

Xuzhou Medical University
Benzodiazepine Derivatives as Potent Vasopressin V

Xuzhou Medical University
Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis.

Wuhan University
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.

Hangzhou Institute For Advanced Study
Amino acid conjugates as kappa opioid receptor agonists.

Adolor
Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.

Adolor
Discovery of 2,4-pyrimidinediamine derivatives as potent dual inhibitors of ALK and HDAC.

Chongqing Medical University
P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl alpha-ketoamide based HCV protease inhibitors.

Eli Lilly
3-Acylamino-azetidin-2-one as a novel class of cysteine proteases inhibitors.

Currently Naeja Pharmaceutical
Design and synthesis of 6-substituted amino-4-oxa-1-azabicyclo[3,2,0]heptan-7-one derivatives as cysteine proteases inhibitors.

Currently Naeja Pharmaceutical
Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.

Heptares Therapeutics
Triazole-Based Inhibitors of the Wnt/β-Catenin Signaling Pathway Improve Glucose and Lipid Metabolisms in Diet-Induced Obese Mice.

University of Maryland
Multipotent AChE and BACE-1 inhibitors for the treatment of Alzheimer's disease: Design, synthesis and bio-analysis of 7-amino-1,4-dihydro-2H-isoquilin-3-one derivates.

Central South University
Design, synthesis and biological evaluation of dual acetylcholinesterase and phosphodiesterase 5A inhibitors in treatment for Alzheimer's disease.

Central South University